NCT01182181View on ClinicalTrials.gov

Anastrozole 1 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Healthy
Interventions
DRUG

Anastrozole (Teva Pharmaceuticals USA)

1 mg Tablets

DRUG

Anastrozole (Arimidex®)

1 mg Tablets

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01182181 - Anastrozole 1 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter